INTERPHEX

Companies Reveal Their Next Moves in Manufacturing
May 29, 2025

In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, sustainability, and the increasing utility of automation.

Geopolitical Shifts Change Nature of Pharma Partnerships
May 28, 2025

The concerns of industry experts expressed at INTERPHEX in April 2025 are still pertinent in an uncertain global political climate.

Tariff Pause Reinforces Uncertainty Among Biopharma Professionals
April 10, 2025

Even with, or perhaps because of, the rapidity with which changes in United States policy are developing, many in the bio/pharmaceutical industry are taking a longer view.

INTERPHEX 2025: Preventing Spills in the Manufacturing Process
April 08, 2025

Joe Bobacher of OPW Engineered Systems spoke with Pharmaceutical Technology® Group at INTERPHEX 2025 about fluid transfer in controlled environments and the importance of guarding against product loss.

INTERPHEX 2025: ‘Breaking Up the Octopus’ of Single-Use Systems
April 07, 2025

As single use becomes more prevalent, end users are looking for more customization, and regulators are refining their rules, says Todd Andrews of CPC in an interview with Pharmaceutical Technology® Group.

INTERPHEX 2025: Advanced Flow Sensor Technologies Enable More Accurate Measurement
April 04, 2025

Michael Franco, global sales director at PSG Biotech, spoke with the PharmTech Group at INTERPHEX 2025 about recent advancements in pharmaceutical flow sensor technology.

INTERPHEX 2025: Advancing Treatments for Ultra-Rare Diseases
April 04, 2025

In part two of Pharmaceutical Technology® Group's discussion with Joe Katakowski, director of Research at the RTW Foundation, the work of organizations like RTW Foundation in promoting the development of treatments for ultra-rare diseases is discussed.

Recapping INTERPHEX 2025: Pharma Looks Toward the Future
April 04, 2025

The yearly convention in New York City showcased new and emerging technologies and gave participating exhibitors a chance to unveil their strategies for the second half of the 2020s.

INTERPHEX 2025: Challenges in Ultra-Rare Disease Treatment Development
April 04, 2025

The Pharmaceutical Technology® Group sat down with Joe Katakowski, director of Research at the RTW Foundation about the challenges involved in the development of treatments for ultra-rare diseases.

Pharma 4.0: What are Industry Leaders Prioritizing in the Modernization of Pharmaceutical Manufacturing?
April 03, 2025

The move towards “pharma 4.0” requires a major shift, both ideologically and technologically, to adapt current processes to a framework that will automate much of today’s manufacturing.